Results for ''
A new guide aims to support healthcare professionals in understanding and critically evaluating observational studies that use real-world data - a rapidly growing area of medical research.
We spoke to Professor William Whiteley, Associate Director for Brain Health at HDR UK, about why brain health research is so important right now and discover what he hopes the future of the space...
A landmark, population-scale study delivers important findings about rare diseases and COVID-19, to better support clinicians and policy-makers.
HDR UK welcomes the Chancellor of the Exchequer’s pledge of £650 million for the UK’s life sciences including £121 million to improve clinical trials to bring new medicines to patients faster.
EMPA-KIDNEY is an international clinical trial by Oxford Population Health scientists in collaboration with academics spanning eight countries. The study recruited over 6000 participants to...
In a commentary published today, HDR UK researchers describe how a key roadblock to using the UK’s rich resources of health data can be removed to make clinical trials faster and more efficient.
A large-scale clinical trial of a monoclonal antibody treatment for COVID-19 showed that it could reduce deaths by 21 per cent in people who had not mounted a natural antibody response of their own.
We explore how routinely collected health data may hold the key to super-charging how clinical trials are delivered, and in turn, how quickly we can bring improvements to people's lives.
